Concord Biotech Limited

Equities

CONCORDBIO

INE338H01029

Market Closed - NSE India S.E. Other stock markets 03:56:15 08/07/2025 pm IST			5-day change	1st Jan Change
1,793.00 ^INR	+1.83%		-2.53%	-18.90%

08/07	Concord Biotech Limited, Q4 2025 Earnings Call, May 30, 2025
02/07	Stellon Biotech Inc announced that it has received $0.0015 million in funding from Concord Biotech Limited	CI

Concord Biotech Limited, Q3 2025 Earnings Call, Feb 14, 2025

Published on 14/02/2025 at 16:00

Presentation Operator Message
Operator (Operator)

Ladies and gentlemen, good day, and welcome to the Q3 FY '25 earnings conference call of Concord Biotech Limited hosted by JM Financial.

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Concord Biotech Limited

Concord Biotech Limited, Q4 2025 Earnings Call, May 30, 2025	08/07
Stellon Biotech Inc announced that it has received $0.0015 million in funding from Concord Biotech Limited	02/07	CI
Concord Biotech Acquires 75% Stake in US-Based Stellon Biotech	02/07	MT
Concord Biotech Gets US FDA's Closure Report for Dholka, India Unit with 'No Regultory Action Needed'	24/06	MT
Jefferies Adjusts Concord Biotech's Price Target to INR1,700 From INR1,620, Keeps at Hold	02/06	MT
Concord Biotech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2025	29/05	CI
Concord Biotech Limited Appoints Ms. Hina Patel as Company Secretary and Compliance Officer, Effective May 30, 2025	29/05	CI
Concord Biotech Limited Announces Resignation of Prakash Sajnani as Company Secretary & Compliance Officer, Effective May 29, 2024	13/05	CI
Concord Biotech Gets US FDA Marketing Nod for Teriflunomide	09/04	MT
Concord Biotech Says Granted Approval From USFDA For Marketing Its Teriflunomide Tablets	08/04	RE
Concord Biotech Commences Production At New Valthera Facility	25/03	RE
Concord Biotech Says MFDS Completes Inspection At Concord Biotech's Dholka Unit	20/02	RE
Jefferies Adjusts Concord Biotech's Price Target to INR1,620 From INR2,080, Keeps at Hold	17/02	MT
Concord Biotech Limited, Q3 2025 Earnings Call, Feb 14, 2025	14/02
20,923,242 Equity Shares of Concord Biotech Limited are subject to a Lock-Up Agreement Ending on 11-FEB-2025.	11/02	CI
Clean Max Everglades Private Limited announced that it expects to receive INR 0.026 million in funding from Concord Biotech Limited	16/01	CI
Jefferies Adjusts Concord Biotech's Price Target to INR1,720 From INR1,480, Keeps at Hold	13/11	MT
Concord Biotech Limited, Q2 2025 Earnings Call, Nov 12, 2024	12/11
Concord Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024	11/11	CI
Jefferies Adjusts Concord Biotech's Price Target to INR1,480 From INR1,410, Keeps at Hold	13/24/13	MT
Concord Biotech Limited, Q1 2025 Earnings Call, Aug 12, 2024	12/24/12
Concord Biotech Limited Reports Earnings Results for the First Quarter Ended June 30, 2024	09/24/09	CI
Concord Biotech Gets EU Good Manufacturing Practices Certificate for Valthera Facility in India	06/24/06	MT
Concord Biotech Limited Announces Health Product Regulatory Authority of Ireland Issues EUGMP Certificate	05/24/05	CI
Concord Biotech Limited, Q4 2024 Earnings Call, May 28, 2024	28/24/28